Aemetis Inc. (DE) (AMTX) Financial Statements (2026 and earlier)

Company Profile

Business Address 20400 STEVENS CREEK BLVD
CUPERTINO, CA 95014
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 286 - Industrial Organic Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,8945,5841,645499898296
Cash and cash equivalent4,8945,5841,645499898296
Receivables4841,6492,6991,04314,1058,027
Inventory, net of allowances, customer advances and progress billings11,6274,77712,37122,93025,44219,792
Inventory11,6274,77712,37122,93025,44219,792
Prepaid expense1,5311,6331,5401,8701,8421,781
Other current assets8,3361,9111,8312,1512,4095,004
Total current assets:26,87215,55420,08628,49344,69634,900
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization2,4292,4522,4802,5102,540 
Operating lease, right-of-use asset2,2562,3702,4922,1242,2372,333
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization201,397191,645186,321181,115181,072195,939
Restricted cash and investments      
Other undisclosed noncurrent assets26,88729,09828,63728,27628,75714,253
Total noncurrent assets:232,969225,565219,930214,025214,606212,525
TOTAL ASSETS:259,841241,119240,016242,518259,302247,425
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23,41829,90321,89432,11533,13937,254
Accounts payable23,41829,90321,89432,11533,13937,254
Debt317,869286,715270,610119,54790,53477,215
Other liabilities29,97126,74729,42322,93920,29517,773
Total current liabilities:371,258343,365321,927174,601143,968132,242
Noncurrent Liabilities
Long-term debt and lease obligation      247,548
Long-term debt, excluding current maturities      244,991
Finance lease, liability      2,557
Liabilities, other than long-term debt131,519135,818133,722131,868131,7357,171
Financial instruments subject to mandatory redemption, settlement terms, share value, amount126,910131,010128,880126,759126,593 
Other liabilities4,6094,8084,8425,1095,1425,232
Operating lease, liability      1,939
Other undisclosed noncurrent liabilities63,89566,78873,622216,744247,527119,373
Total noncurrent liabilities:195,414202,606207,344348,612379,262374,092
Total liabilities:566,672545,971529,271523,213523,230506,334
Equity
Equity, attributable to parent(306,831)(304,852)(289,255)(280,695)(263,928)(258,909)
Common stock666562545148
Additional paid in capital340,402336,814327,905313,075305,329293,611
Accumulated other comprehensive loss(7,356)(7,118)(6,356)(6,353)(6,366)(5,823)
Accumulated deficit(639,943)(634,613)(610,866)(587,471)(562,942)(546,745)
Total equity:(306,831)(304,852)(289,255)(280,695)(263,928)(258,909)
TOTAL LIABILITIES AND EQUITY:259,841241,119240,016242,518259,302247,425

Income Statement (P&L) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Revenues43,30759,19052,24342,88647,00481,441
Cost of revenue
(Cost of Product and Service Sold)
(45,937)(59,248)(55,598)(47,966)(49,044)(77,563)
Other undisclosed gross profit 10,355     
Gross profit:7,725(58)(3,355)(5,080)(2,040)3,878
Operating expenses(10,206)(8,450)(7,319)(10,475)(11,436)(7,750)
Operating loss:(2,481)(8,508)(10,674)(15,555)(13,476)(3,872)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1,530(249)1,1122151901,225
Interest and debt expense(13,939)(12,950)(12,330)(13,693)(12,637)(11,747)
Loss from continuing operations before equity method investments, income taxes:(14,890)(21,707)(21,892)(29,033)(25,923)(14,394)
Other undisclosed loss from continuing operations before income taxes (1,881)(2,034)(2,032)(2,279)(2,643)(3,267)
Loss from continuing operations before income taxes:(16,771)(23,741)(23,924)(31,312)(28,566)(17,661)
Income tax expense (benefit)11,441(6)5296,78312,369(274)
Net loss available to common stockholders, diluted:(5,330)(23,747)(23,395)(24,529)(16,197)(17,935)

Comprehensive Income ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net loss:(5,330)(23,747)(23,395)(24,529)(16,197)(17,935)
Comprehensive loss:(5,330)(23,747)(23,395)(24,529)(16,197)(17,935)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(238)(762)(3)13(543)(116)
Comprehensive loss, net of tax, attributable to parent:(5,568)(24,509)(23,398)(24,516)(16,740)(18,051)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: